• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过增加肿瘤坏死因子(TNF)N 端区域的碱性来提高其细胞毒性。

Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.

作者信息

Soma G, Kitahara N, Tsuji Y, Kato M, Oshima H, Gatanaga T, Inagawa H, Noguchi K, Tanabe Y, Mizuno D

机构信息

Biotechnology Research Center, Teikyo University, Kanagawa, Japan.

出版信息

Biochem Biophys Res Commun. 1987 Oct 29;148(2):629-35. doi: 10.1016/0006-291x(87)90923-5.

DOI:10.1016/0006-291x(87)90923-5
PMID:3318824
Abstract

Two new recombinant TNFs (named rTNF-Scw1 and -Scw2) with higher basicity than conventional recombinant human TNF-alpha (rTNF-alpha) in the N-terminal region were constructed. Their sequences were constructed based on those of partially purified cytotoxic factors from the culture supernatant of acute monocytic leukemia cells THP-1, which unlike rTNF-alpha are cytotoxic to T24 bladder carcinoma cells in vitro. These new rTNF-Ss showed a broader cytotoxicity to tumor cells than rTNF-alpha. This increase in the basicity of the N-terminal region over that of conventional TNF significantly increased the cytotoxicity on tumor cells in vivo as well as in vitro.

摘要

构建了两种新的重组肿瘤坏死因子(分别命名为rTNF-Scw1和-Scw2),其N端区域的碱性高于传统重组人肿瘤坏死因子-α(rTNF-α)。它们的序列是基于急性单核细胞白血病细胞THP-1培养上清液中部分纯化的细胞毒性因子构建的,与rTNF-α不同,这些细胞毒性因子在体外对T24膀胱癌细胞具有细胞毒性。这些新的rTNF-Ss对肿瘤细胞的细胞毒性比rTNF-α更广。与传统肿瘤坏死因子相比,N端区域碱性的增加显著提高了其在体内和体外对肿瘤细胞的细胞毒性。

相似文献

1
Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.通过增加肿瘤坏死因子(TNF)N 端区域的碱性来提高其细胞毒性。
Biochem Biophys Res Commun. 1987 Oct 29;148(2):629-35. doi: 10.1016/0006-291x(87)90923-5.
2
Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells.
J Biol Response Mod. 1988 Dec;7(6):587-95.
3
High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris.
Biochemistry. 1989 May 2;28(9):4117-25. doi: 10.1021/bi00435a074.
4
A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
Int J Cancer. 1991 Jul 9;48(5):744-8. doi: 10.1002/ijc.2910480519.
5
A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1.
Microbiol Immunol. 1999;43(1):53-9. doi: 10.1111/j.1348-0421.1999.tb02372.x.
6
Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.丁基羟基茴香醚可抑制肿瘤坏死因子诱导的细胞毒性和花生四烯酸释放。
Lipids. 1994 Feb;29(2):91-102. doi: 10.1007/BF02537148.
7
The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.肿瘤坏死因子(TNF)的抗肿瘤功能,I. TNF对已形成的小鼠肉瘤的治疗作用是间接的、免疫依赖的,并受到严重毒性的限制。
J Exp Med. 1988 Mar 1;167(3):1067-85. doi: 10.1084/jem.167.3.1067.
8
Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.重组肿瘤坏死因子与参与单核细胞介导细胞毒性的单核细胞衍生细胞毒性因子的比较。
Cancer Res. 1987 May 1;47(9):2251-8.
9
Expression and characterization of bioactive recombinant ovine TNF-alpha: some species specificity in cytotoxic response to TNF.生物活性重组绵羊肿瘤坏死因子-α的表达与特性:对肿瘤坏死因子细胞毒性反应中的一些物种特异性
Cytokine. 1993 May;5(3):213-23. doi: 10.1016/1043-4666(93)90007-r.
10
Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.新型重组肿瘤坏死因子(rTNF-S)全身给药的抗肿瘤作用,其在体内的毒性低于传统的rTNF-α。
J Biol Response Mod. 1989 Jun;8(3):278-86.

引用本文的文献

1
Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity.新型人肿瘤坏死因子-α的安全性评价及药代动力学研究显示其具有更高的抗肿瘤活性和更低的全身毒性。
Anticancer Drugs. 2010 Mar;21(3):243-51. doi: 10.1097/cad.0b013e328333d5ce.
2
A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice.重组人肿瘤坏死因子-α及其突变体对小鼠白血病 L1210 和白血病 P388 的抗白血病作用比较。
Mediators Inflamm. 1994;3(6):411-4. doi: 10.1155/S0962935194000578.
3
The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.
肿瘤坏死因子-α(TNF-α)突变体对人嗜中性粒细胞的体外影响。
Mediators Inflamm. 1993;2(1):41-8. doi: 10.1155/S0962935193000055.
4
Human lymphotoxin mutein lacks hypotensive activity but has higher in vivo antitumor activity than lymphotoxin or tumor necrosis factor.人淋巴毒素突变体缺乏降压活性,但在体内具有比淋巴毒素或肿瘤坏死因子更高的抗肿瘤活性。
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3324-9. doi: 10.1073/pnas.94.7.3324.
5
Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity.一种具有增强细胞毒性活性的新型人类肿瘤坏死因子-α突变体的特性分析。
Jpn J Cancer Res. 1995 Jan;86(1):72-80. doi: 10.1111/j.1349-7006.1995.tb02990.x.
6
Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis.通过突变分析对人肿瘤坏死因子(hTNF)活性位点进行定位。
EMBO J. 1991 Apr;10(4):827-36. doi: 10.1002/j.1460-2075.1991.tb08015.x.